Suppr超能文献

摩洛哥与新冠病毒感染相关的儿童多系统炎症综合征(MIS-C)

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.

作者信息

Amenzoui Naima, Zouiter Siham, Nassid Meriem, Kholaiq Halima, Belkhou Ikbal, Benhsaien Ibtihal, Ailal Fatima, Adnane Fatima, Jouhadi Zineb, Bousfiha Ahmed Aziz

机构信息

Clinical Immunology and Infectious Pediatrics Department, Abderrahim Harouchi Mother and Childrens Hospital, Casablanca, Morocco.

Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Faculty of Medicine and Pharmacy, Morocco.

出版信息

Glob Pediatr Health. 2024 Oct 28;11:2333794X241286772. doi: 10.1177/2333794X241286772. eCollection 2024.

Abstract

. This study aims to describe the clinical and paraclinical characteristics of Multisysteminflammatory syndrome in children (MIS-C). . A retrospective study encompassing 52 children diagnosed with MIS-C according to the World Health Organization criteria, over a 3-year period at Abderrahim Harrouchi Hospital in Morocco. . The median age was 6 years (IQR: 1-14), with a sex ratio of 1.16 (28 boys and 24 girls). Clinical manifestations were predominantly characterized by fever in all cases (100%), respiratory and gastrointestinal symptoms in 30 cases (58%) and 23 cases (44%) respectively, and shock in 9 cases (17%). We noted a myocarditis in 6 cases (12%). The treatment comprised intravenous human Immunoglobulin combined with methylprednisolone in all patients (100%). . The characteristics of our MIS-C patients were similar to those in the literature, but more studies are needed to confirm these results.

摘要

本研究旨在描述儿童多系统炎症综合征(MIS-C)的临床和辅助检查特征。这是一项回顾性研究,在摩洛哥阿卜杜勒拉希姆·哈鲁奇医院对52名根据世界卫生组织标准诊断为MIS-C的儿童进行了为期3年的研究。中位年龄为6岁(四分位间距:1 - 14岁),性别比为1.16(28名男孩和24名女孩)。临床表现主要特征为所有病例均有发热(100%),30例(58%)有呼吸道症状,23例(44%)有胃肠道症状,9例(17%)有休克。我们注意到6例(12%)有心肌炎。所有患者(100%)的治疗包括静脉注射人免疫球蛋白联合甲泼尼龙。我们的MIS-C患者特征与文献中的相似,但需要更多研究来证实这些结果。

相似文献

1
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.
Glob Pediatr Health. 2024 Oct 28;11:2333794X241286772. doi: 10.1177/2333794X241286772. eCollection 2024.
2
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population.
Eur J Pediatr. 2024 Apr;183(4):1693-1702. doi: 10.1007/s00431-023-05383-5. Epub 2024 Jan 12.
4
Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study).
J Paediatr Child Health. 2022 Jun;58(6):1069-1078. doi: 10.1111/jpc.15913. Epub 2022 Feb 24.
6
[Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
Zhonghua Er Ke Za Zhi. 2024 Jan 2;62(1):55-59. doi: 10.3760/cma.j.cn112140-20231021-00309.
8
Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves.
Eur J Pediatr. 2023 Apr;182(4):1647-1656. doi: 10.1007/s00431-022-04790-4. Epub 2023 Jan 31.
9
Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam.
Pediatr Neonatol. 2022 Nov;63(6):569-574. doi: 10.1016/j.pedneo.2022.05.009. Epub 2022 Jul 8.

本文引用的文献

3
Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg.
Front Pediatr. 2023 Apr 5;11:1141074. doi: 10.3389/fped.2023.1141074. eCollection 2023.
4
[Should we interfere with the interleukin-6 receptor during COVID-19: What do we know?].
Rev Mal Respir. 2023 Jan;40(1):24-37. doi: 10.1016/j.rmr.2022.11.085. Epub 2022 Dec 9.
5
[Diagnosis of a pediatric inflammatory multisystemic syndrome associated with COVID-19].
J Pediatr Pueric. 2023 Feb;36(1):1-7. doi: 10.1016/j.jpp.2022.11.001. Epub 2022 Nov 15.
9
Multisystem Inflammatory Syndrome in Children (MIS-C).
Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验